Evidence map›Paper›PMID 41006934›Full record

ReviewMedical oncology (Northwood, London, England)2025

Therapeutic implications of vitamin D in leukemia: mechanistic and clinical perspectives.

Elham Moasser, Yasin Parvizi, Alireza Samavati, Parmis Taghizadeh, Alireza Moasser, Tahereh Zarei, Mani Ramzi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elham MoasserHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. elhammoasser@gmail.com.
Yasin ParviziCancer Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamedan University of Medical Sciences, Hamedan, Iran.
Alireza SamavatiStudent Research Committee, Hamedan University of Medical Sciences, Hamedan, Iran.
Parmis TaghizadehSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza MoasserSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Tahereh ZareiHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mani RamziHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Ramzim@sums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent research has highlighted vitamin D's potential role in the development and treatment of hematological cancers, expanding its known importance beyond calcium regulation and bone health. Patients with blood disorders often exhibit lower serum concentrations of 25(OH)D3, the precursor to calcitriol (1,25(OH)

Indexed as

LeukemiaVitamin DAnimalsHumansReceptors, CalcitriolReceptors, CalcitriolVitamin DDifferentiation therapyLeukemiaSignaling pathwaysVitamin DVitamin D receptor (VDR)

Identifiers

PMID41006934

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.